Neuronetics is trading 5.75% up at $2.92 as broader risk appetite improved on September 17, 2026.
- Nasdaq Composite rose 1.41% and S&P 500 rose 0.93%, supporting growth-stock sentiment.
- No new company-specific announcement was identified September 17; latest notable coverage was B. Rileyβs September 11 Buy initiation and $5 price target.
- The move appears macro-driven; activity is elevated versus recent weakness, with volume unavailable.